Primary ALK-Negative Anaplastic Large Cell Lymphoma Mimicking Septic Arthritis in a Diabetic Patient: Diagnostic and Therapeutic Challenges
Journal of Visualized Experiments · 2025
DOI: 10.3791/69086 ↗At a glance
Fallbericht in Journal of Visualized Experiments, 2025. Written by Kun Li and 7 co-authors. Institution: Department of Critical Care Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine; Likicu@zju.edu.cn. Major MEDLINE topics: Arthritis, Infectious, Diabetes Complications, Lymphoma, Large-Cell, Anaplastic. 39 references.
Abstract (original language)
Anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma (ALCL) is a rare, aggressive subtype of peripheral T-cell lymphoma that frequently presents with atypical features, creating substantial diagnostic challenges. Primary ALK-negative ALCL arising from the knee joint is exceptionally uncommon. This report describes a patient who was initially misdiagnosed with septic arthritis of the knee due to localized pain, swelling, and erythema. The delayed diagnosis illustrates the difficulty of distinguishing hematologic malignancies from common infectious conditions, particularly in immunocompromised individuals. At the time of diagnosis, the disease was at an advanced stage IVB and complicated by septicemia, septic shock, and pneumonia, limiting tolerance for intensive chemotherapy. A carefully staged treatment plan was employed, beginning with corticosteroids and etoposide, followed by liposomal mitoxantrone and the CD30-targeted antibody-drug conjugate brentuximab vedotin. This multidisciplinary approach led to clinical stabilization, recovery from critical illness, and eventual discharge, with ongoing hematologic follow-up. The clinical course highlights the necessity of maintaining a high index of suspicion for lymphoma in refractory joint infections and demonstrates that individualized, stepwise therapy can achieve remission even in critically ill patients with aggressive ALCL. These findings provide valuable insights for improving the diagnosis and management of lymphoma cases that mimic infectious diseases.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Critical Care Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine; Likicu@zju.edu.cn.
- Department of Nursing, Hangzhou Xiaoying Community Health Service Center.
- Department of Pathology, The First Affiliated Hospital, Zhejiang University School of Medicine.
- Department of Orthopaedics, The First Affiliated Hospital, Zhejiang University School of Medicine.
- Department of Orthopedic, The Second Affiliated Hospital of Zhejiang Chinese Medical University.
- Department of Orthopedics, No. 903 Hospital of PLA Joint Logistic Support Force.
Cite
APA
Li, K., Pan, X., Chen, Q., Alhaskawi, A., Dong, Y., Zou, X., Zhou, W., & Lu, H. (2025). Primary ALK-Negative Anaplastic Large Cell Lymphoma Mimicking Septic Arthritis in a Diabetic Patient: Diagnostic and Therapeutic Challenges. Journal of Visualized Experiments. https://doi.org/10.3791/69086
Vancouver
Li K, Pan X, Chen Q, Alhaskawi A, Dong Y, Zou X, et al. Primary ALK-Negative Anaplastic Large Cell Lymphoma Mimicking Septic Arthritis in a Diabetic Patient: Diagnostic and Therapeutic Challenges. Journal of Visualized Experiments. 2025. doi:10.3791/69086
BibTeX
@article{Li2025,
author = {Li, Kun and Pan, Xuejia and Chen, Qing and Alhaskawi, Ahmad and Dong, Yanzhao and Zou, Xiaodi and Zhou, Weijie and Lu, Hui},
title = {Primary ALK-Negative Anaplastic Large Cell Lymphoma Mimicking Septic Arthritis in a Diabetic Patient: Diagnostic and Therapeutic Challenges},
journal = {Journal of Visualized Experiments},
year = {2025},
doi = {10.3791/69086}
}
EUVIMED